Recent Quotes
My Watchlist
Indicators
REW 40 Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Astrana Health Inc. - Common Stock (NQ:ASTH)

39.38 +0.38 (+0.96%)
Streaming Delayed Price Updated: 1:18 PM EDT, May 13, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Astrana Health Inc. - Common Stock

< Previous 1 2 3 4 Next >
News headline image
Astrana Health Says Prospect Deal Is Ahead of Schedule as Q1 Trends Beat Expectations ↗
Astrana Health (NASDAQ:ASTH) CEO and President Brandon Sim said the value-based care company is seeing early benefits from its acquisition of Prospect, while reporting stronger-than-expected... 
Via MarketBeat
Topics Bankruptcy
News headline image
1 Unpopular Stock That Deserves a Second Chance and 2 That Underwhelm
When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fea... 
Via StockStory
News headline image
Astrana Health (ASTH) Q1 2026 Earnings Transcript ↗
Astrana Health (ASTH) Q1 2026 Earnings Transcript 
Via The Motley Fool
Topics Artificial Intelligence
Astrana Health (NASDAQ:ASTH) Post-Earnings Slide: Revenue Beat Fails to Offset EPS Miss ↗
Via Chartmill
Astrana Health Inc (NASDAQ:ASTH) Reports Strong Q4 Earnings Beat and 42.9% Revenue Growth ↗
Via Chartmill
Topics Earnings
News headline image
ASTH Q1 Deep Dive: AI-Enabled Platform, Full-Risk Expansion, and Operating Leverage Shape Results
Healthcare services company Astrana Health reported revenue ahead of Wall Street’s expectations in Q1 CY2026, with sales up 55.6% year on year to $965.1 mill... 
Via StockStory
Topics Artificial Intelligence
News headline image
Astrana Health (NASDAQ:ASTH) Beats Q1 CY2026 Sales Expectations
Healthcare services company Astrana Health reported Q1 CY2026 results topping the market’s revenue expectations, with sales up 55.6% year on year to $965.1 m... 
Via StockStory
News headline image
Astrana Health (ASTH) Q1 Earnings Report Preview: What To Look For
Healthcare services company Astrana Health will be reporting results this Thursday afternoon. Here’s what to look for. Astrana Health beat analysts’ revenue ... 
Via StockStory
Topics Artificial Intelligence
News headline image
2 Profitable Stocks on Our Watchlist and 1 Facing Headwinds
While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifi... 
Via StockStory
News headline image
1 Healthcare Stock to Target This Week and 2 We Ignore
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Despite the rosy long-term prospects, short-... 
Via StockStory
News headline image
1 Surging Stock with Competitive Advantages and 2 We Ignore
The stocks featured in this article are seeing some big returns. Over the past month, they’ve outpaced the market due to some combination of positive news, u... 
Via StockStory
News headline image
3 Growth Stocks to Add to Your Roster
Growth boosts valuation multiples, but it doesn’t always last forever. Companies that cannot maintain it are often penalized with large declines in market va... 
Via StockStory
News headline image
2 Stocks Under $50 for Long-Term Investors and 1 Facing Challenges
The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk tha... 
Via StockStory
News headline image
Astrana Health, Evolent Health, Neogen, agilon health, and Fortrea Shares Are Soaring, What You Need To Know
What Happened? A number of stocks jumped in the afternoon session after the government announced a surprise increase in payment rates for Medicare Advantage ... 
Via StockStory
News headline image
1 Small-Cap Stock to Keep an Eye On and 2 Facing Challenges
Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and... 
Via StockStory
Topics Credit Cards
News headline image
2 Reasons to Like ASTH (and 1 Not So Much)
Although the S&P 500 is down 3.2% over the past six months, Astrana Health’s stock price has fallen further to $24.18, losing shareholders 14.7% of their cap... 
Via StockStory
Topics Artificial Intelligence Stocks
News headline image
Healthcare Technology for Providers Stocks Q4 Recap: Benchmarking Astrana Health (NASDAQ:ASTH)
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how healthcare techno... 
Via StockStory
News headline image
1 of Wall Street’s Favorite Stock with Exciting Potential and 2 We Avoid
Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remember... 
Via StockStory
News headline image
Why Astrana Health (ASTH) Stock Is Up Today
Shares of healthcare services company Astrana Health jumped 25.3% in the afternoon session after the company reported its fourth-quarter 2025 results, featuring strong revenue growth and a significant... 
Via StockStory
Topics Economy
Let's uncover which stocks are experiencing notable gaps during today's session. ↗
Via Chartmill
News headline image
Astrana Health (ASTH) Q4 2025 Earnings Transcript ↗
Astrana Health (ASTH) Q4 2025 Earnings Transcript 
Via The Motley Fool
News headline image
Astrana Health (NASDAQ:ASTH) Beats Q4 CY2025 Sales Expectations
Healthcare services company Astrana Health reported Q4 CY2025 results beating Wall Street’s revenue expectations, with sales up 42.9% year on year to $950.5 million. The company expects next quarter’s... 
Via StockStory
News headline image
1 Russell 2000 Stock Worth Investigating and 2 We Avoid
The Russell 2000 (^RUT) is packed with potential breakout stocks, thanks to its focus on smaller companies with high growth potential. However, smaller size also means these businesses often lack the... 
Via StockStory
News headline image
1 Stock Under $50 with Exciting Potential and 2 We Brush Off
Stocks trading between $10 and $50 can be particularly interesting as they frequently represent businesses that have survived their early challenges. However, investors should remain vigilant as some... 
Via StockStory
News headline image
Inspire Medical Systems, Astrana Health, Evolent Health, Corcept, and Centene Stocks Trade Up, What You Need To Know
A number of stocks jumped in the afternoon session after a softer-than-expected inflation report fueled hopes for interest rate cuts by the Federal Reserve. The January Consumer Price Index (CPI), a... 
Via StockStory
Topics Economy
News headline image
2 Reasons to Like ASTH (and 1 Not So Much)
Astrana Health’s stock price has taken a beating over the past six months, shedding 34.6% of its value and falling to $19.04 per share. This was partly due to its softer quarterly results and may have... 
Via StockStory
News headline image
1 Volatile Stock with Exciting Potential and 2 That Underwhelm
Market swings can be tough to stomach, and volatile stocks often experience exaggerated moves in both directions. While many thrive during risk-on environments, many also struggle to maintain investor... 
Via StockStory
Topics Economy
News headline image
Astrana Health (ASTH): Buy, Sell, or Hold Post Q3 Earnings?
Astrana Health currently trades at $21.98 per share and has shown little upside over the past six months, posting a small loss of 1.5%. The stock also fell short of the S&P 500’s 9.8% gain during that... 
Via StockStory
Topics Stocks
News headline image
Healthcare Technology for Providers Stocks Q3 Recap: Benchmarking Astrana Health (NASDAQ:ASTH)
As the Q3 earnings season wraps, let’s dig into this quarter’s best and worst performers in the healthcare technology for providers industry, including Astrana Health (NASDAQ:ASTH) and its peers. 
Via StockStory
News headline image
2 of Wall Street’s Favorite Stocks with Promising Prospects and 1 We Question
Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional... 
Via StockStory
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.